Banner

Tumor necrosis factor alpha gene level in patients with tympanosclerosis

• 2021
العودة
معلومات البحث
المؤلفون M.F.Shendy1 , Y.M.Mandour1 , S.A.Mohammed2 , A.H.El-zobeir1 and A.Abdel-aal
الكلمات المفتاحية Not Available
المجلة العلمية Not Available
الناشر Not Available
المجلد Not Available
العدد Not Available
الصفحات Not Available
publication.type Local
رابط البحث Not Available
المواد المرفقة Not Available
الملخص
Background: Tympanosclerosis is the calcification of connective tissue in the middle ear, particularly the tympanic
membrane, which can arise following middle ear infection. Inflammatory reactions are induced and maintained by tumour
necrosis factor (TNF) in a variety of illnesses, including chronic otitis media with effusion (COME). The goal of this study
was to determine the plasma level of Tumer necrosis factor (TNF) gene expression in individuals who had
tympanosclerosis as a result of ventilation tube insertion. Methods: This study comprised sixty patients who were separated
into two groups: 60 patients were assigned to Group A based on inclusion and exclusion criteria, whereas 20 volunteers
were assigned to Group B. Patients were given a medical history, a thorough physical examination, and a TNF- gene
expression test in the lab (qRT-PCR). Results: There was a significant difference in TNF-gene expression across groups,
with the mean TNF in the cases group (3.87) being significantly greater than the control group (1), p0.001. TNF levels
were statistically different depending on the number of tubes inserted (p=0.005) and the time of secretory OM (p=0.042).
There was no significant difference in TNF levels when it came to medication usage or acute OM episodes. Conclusion:
TNF- gene profile expression was statistically significant higher in selected middle-ear structures with tympanosclerosis
than in the control group.